Quick Answer
ENANTA PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 21.39 million shares for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed an increase of +0.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: 17.83 million shares | Q4 2013: 17.97 million shares | Q1 2014: 18.48 million shares | Q2 2014: 18.58 million shares | Q4 2014: 18.61 million shares | Q1 2015: 18.69 million shares | Q2 2015: 18.71 million shares | Q4 2015: 18.80 million shares | Q1 2016: 18.96 million shares | Q2 2016: 19.04 million shares | Q4 2016: 19.04 million shares | Q1 2017: 19.05 million shares | Q2 2017: 19.09 million shares | Q4 2017: 19.15 million shares | Q1 2018: 19.26 million shares | Q2 2018: 19.36 million shares | Q4 2018: 19.44 million shares | Q1 2019: 19.67 million shares | Q2 2019: 19.68 million shares | Q4 2019: 19.81 million shares | Q1 2020: 19.99 million shares | Q2 2020: 20.07 million shares | Q4 2020: 20.14 million shares | Q1 2021: 20.19 million shares | Q2 2021: 20.21 million shares | Q4 2021: 20.51 million shares | Q1 2022: 20.62 million shares | Q2 2022: 20.72 million shares | Q4 2022: 20.88 million shares | Q1 2023: 21.05 million shares | Q2 2023: 21.06 million shares | Q4 2023: 21.16 million shares | Q1 2024: 21.18 million shares | Q2 2024: 21.18 million shares | Q3 2024: 21.39 million shares | Q4 2024: 21.33 million shares | Q1 2025: 21.38 million shares | Q2 2025: 21.38 million shares | Q4 2025: 29.02 million shares.
- Over the full 14 years of available data (2012 to 2025), ENANTA PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 1,785.4%.
- Historical annual values: Fiscal year 2025: 21.39 million shares | Fiscal year 2024: 21.19 million shares | Fiscal year 2023: 21.06 million shares | Fiscal year 2022: 20.79 million shares | Fiscal year 2021: 20.24 million shares | Fiscal year 2020: 20.08 million shares | Fiscal year 2019: 19.70 million shares | Fiscal year 2018: 19.40 million shares | Fiscal year 2017: 19.12 million shares | Fiscal year 2016: 19.04 million shares | Fiscal year 2015: 18.72 million shares | Fiscal year 2014: 18.59 million shares | Fiscal year 2013: 17.93 million shares | Fiscal year 2012: 1.13 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: